$54.85 Billion in Sales Expected for UnitedHealth Group Inc (UNH) This Quarter

Brokerages forecast that UnitedHealth Group Inc (NYSE:UNH) will announce sales of $54.85 billion for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates for UnitedHealth Group’s earnings. The highest sales estimate is $55.38 billion and the lowest is $54.15 billion. UnitedHealth Group posted sales of $48.72 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 12.6%. The firm is expected to report its next earnings report on Tuesday, April 17th.

According to Zacks, analysts expect that UnitedHealth Group will report full year sales of $54.85 billion for the current financial year, with estimates ranging from $223.50 billion to $225.72 billion. For the next financial year, analysts anticipate that the company will report sales of $242.70 billion per share, with estimates ranging from $240.11 billion to $245.44 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for UnitedHealth Group.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. During the same quarter in the previous year, the company posted $2.11 earnings per share. UnitedHealth Group’s quarterly revenue was up 9.5% compared to the same quarter last year.

A number of research analysts have recently issued reports on UNH shares. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Cantor Fitzgerald restated a “buy” rating and issued a $225.00 price objective on shares of UnitedHealth Group in a research report on Monday, November 27th. Piper Jaffray Companies boosted their price objective on shares of UnitedHealth Group to $228.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 17th. Jefferies Group restated a “buy” rating and issued a $248.00 price objective on shares of UnitedHealth Group in a research report on Friday, December 1st. Finally, Deutsche Bank boosted their price objective on shares of UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $243.22.

UnitedHealth Group (UNH) opened at $231.88 on Friday. UnitedHealth Group has a one year low of $156.49 and a one year high of $250.79. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. The stock has a market cap of $224,707.48, a P/E ratio of 21.65, a PEG ratio of 1.35 and a beta of 0.70.

In other news, Director Kenneth Irwin Shine sold 198 shares of the business’s stock in a transaction on Friday, January 19th. The shares were sold at an average price of $242.55, for a total value of $48,024.90. Following the completion of the transaction, the director now owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Michele J. Hooper sold 10,000 shares of the business’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $237.76, for a total transaction of $2,377,600.00. Following the completion of the transaction, the director now directly owns 37,284 shares of the company’s stock, valued at approximately $8,864,643.84. The disclosure for this sale can be found here. Insiders have sold a total of 53,853 shares of company stock valued at $12,358,508 in the last ninety days. Company insiders own 0.89% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Regal Wealth Group Inc. lifted its position in UnitedHealth Group by 0.4% in the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after acquiring an additional 3 shares in the last quarter. Jackson Grant Investment Advisers Inc. lifted its position in UnitedHealth Group by 0.4% in the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after acquiring an additional 4 shares in the last quarter. RNC Capital Management LLC lifted its position in UnitedHealth Group by 0.7% in the 2nd quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after acquiring an additional 13 shares in the last quarter. Highland Private Wealth Management lifted its position in UnitedHealth Group by 0.4% in the 2nd quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock valued at $593,000 after acquiring an additional 13 shares in the last quarter. Finally, Flagship Harbor Advisors LLC lifted its position in UnitedHealth Group by 0.3% in the 2nd quarter. Flagship Harbor Advisors LLC now owns 5,028 shares of the healthcare conglomerate’s stock valued at $939,000 after acquiring an additional 15 shares in the last quarter. 86.21% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “$54.85 Billion in Sales Expected for UnitedHealth Group Inc (UNH) This Quarter” was first published by American Banking News and is owned by of American Banking News. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/02/04/54-85-billion-in-sales-expected-for-unitedhealth-group-inc-unh-this-quarter.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply